医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Intertek Explains What Third Party Auditing and Certification All About

2015年02月12日 PM10:44
このエントリーをはてなブックマークに追加


 

LONDON

Intertek, the global testing, auditing and certification organisation, are delighted to have been invited to speak at the forthcoming Global Food Safety Conference (GFSI), to be held in Kuala Lumpur, Malaysia on the 3rd to 5th March. This year GFSI is bound for Asia for the first time following successful editions in California, Barcelona, Orlando and London. The theme for the 2015 event is “Food Safety: A Shared Responsibility” with a programme of topics centred on this over the three conference days.

Anthony Liang, Intertek’s Technical Director for food certification in APAC, will be one of the first speakers of the day and will deliver a presentation on “What is third party auditing and certification” during the induction session on the 3rd March, aimed at first-time attendees to the event. Attendees can expect an engaging seminar on the wealth of available food auditing programmes and certification standards required in an ever-changing global market. All of which help businesses to demonstrate their commitment to food safety, enhance their brand image, build consumer confidence and open the way to new market opportunities.

Anthony Liang is highly experienced in auditing, training, quality management systems and food safety management systems. With his expertise in understanding consumer and business issues, he is ideally placed to provide insight to Food professionals from across the spectrum.

Calin Moldovean, Senior Vice-President at Intertek Food Services, states “It is a privilege to have been invited to present at the forthcoming GFSI conference. The event is not only a fantastic opportunity to network with industry professionals but also to exchange best practices for greater food safety around the world.

Food safety is still a prominent topic for businesses across the globe and with increasing operations in the ASEAN region, we hope though our participation to enable delegates to understand the fundamental approach of the GFSI standards and how they can translate them it into improving food safety in their business. Intertek’s wealth of experience means that our expert testing, auditing and certification services enable us to be the right partner for local, regional and international companies.”

GFSI is a three day conference which brings together internationally respected food safety experts to share the latest thinking and developments in food safety. 1,000 leading food safety specialists and decision-makers from over 50 countries across the globe will be in attendance, providing an excellent opportunity to connect, network and share knowledge with industry peers.

For further information about GFSI 2015 visit http://www.intertek.com/food/gfsi-event/

- ENDS -

About Intertek

Intertek is the leading quality solutions provider to industries worldwide. From auditing and inspection, to testing, training, advisory, quality assurance and certification, Intertek adds value to customers’ products, processes and assets. With a network of more than 1,000 laboratories and offices and over 36,000 people in more than 100 countries, Intertek supports companies’ success in a global marketplace. Intertek helps its customers to meet end users’ expectations for safety, sustainability, performance, integrity and desirability in virtually any market worldwide. For more information visit www.intertek.com.

CONTACT

Intertek
Media
Natalie Harvey
Global Marketing Manager
Tel:
+ 44 (0) 161 245 8077
Email: Natalie.Harvey@intertek.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表